©The Author(s) 2025.
World J Gastrointest Surg. Oct 27, 2025; 17(10): 110836
Published online Oct 27, 2025. doi: 10.4240/wjgs.v17.i10.110836
Published online Oct 27, 2025. doi: 10.4240/wjgs.v17.i10.110836
Table 2 Distribution of comorbidities in patients with liver abscess and fatty liver, n (%)
| Comorbidity | Total (n = 165) | Good prognosis (n = 121) | Poor prognosis (n = 44) | χ² | P value |
| Diabetes mellitus | 98 (59.4) | 67 (55.4) | 31 (70.5) | 6.983 | 0.008 |
| Hypertension | 76 (46.1) | 55 (45.5) | 21 (47.7) | 1.095 | 0.296 |
| Coronary heart disease | 32 (19.4) | 22 (18.2) | 10 (22.7) | 1.211 | 0.271 |
| Dyslipidemia | 84 (50.9) | 56 (46.3) | 28 (63.6) | 7.542 | 0.006 |
| Chronic kidney disease | 26 (15.8) | 14 (11.6) | 12 (27.3) | 8.294 | 0.004 |
| Chronic obstructive pulmonary disease | 18 (10.9) | 12 (9.9) | 6 (13.6) | 0.974 | 0.324 |
| Biliary disease | 54 (32.7) | 35 (28.9) | 19 (43.2) | 5.673 | 0.017 |
- Citation: Zhang L, Yang WF, Wu HD, Zhu HH. Risk factors analysis for poor prognosis after percutaneous drainage in liver abscess patients with fatty liver. World J Gastrointest Surg 2025; 17(10): 110836
- URL: https://www.wjgnet.com/1948-9366/full/v17/i10/110836.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v17.i10.110836